Quantitative measurement of blaCMY-2 in a longitudinal observational study of dairy cattle treated with ceftiofur

Foodborne Pathogens and Disease

Volumn 9, Issue 11, 2012, Pages 1022-1027

  Boyer, Tim C ^a   Singer, Randall S ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CEFTIOFUR; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE CMY 2; BETA-LACTAMASE CMY-2; CEPHALOSPORIN DERIVATIVE;

ANIMAL GENETICS; ANTIBIOTIC RESISTANCE; ARTICLE; BLA CMY2 GENE; CATTLE DISEASE; DAIRY CATTLE; ESCHERICHIA COLI; GENE; LIVESTOCK; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CATTLE; COHORT ANALYSIS; DRUG EFFECT; FECES; FEMALE; GENETICS; LONGITUDINAL STUDY; MICROBIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CATTLE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; COHORT STUDIES; DNA, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; LONGITUDINAL STUDIES; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84869054060     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2012.1198     Document Type: Article

References (37)

1. Alali WQ, Scott HM, Norby B, Gebreyes W, Loneragan GH. Quantification of the BlaCMY-2 in feces from beef feedlot cattle administered three different doses of ceftiofur in a longitudinal controlled field trial. Foodborne Pathog Dis 2009;6: 917-924.
2. Allen KJ, Poppe C. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can J Vet Res 2002;66:137-144.
3. Barlow M, Hall BG. Origin and evolution of the AmpC betalactamases of Citrobacter freundii. Antimicrob Agents Chemother 2002;46:1190-1198. (Pubitemid 34415290)
4. Boyer TC, Hanson T, Singer RS. Estimation of low quantity genes: A hierarchical model for analyzing censored quantitative real-time PCR data. 2012 (submitted).
5. Call DR, Singer RS, Meng D, Broschat SL, Orfe LH, Anderson JM, Herndon DR, Kappmeyer LS, Daniels JB, Besser TE. blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob Agents Chemother 2010;54: 590-596.
6. [CDC] Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human isolates final report, 2010. Atlanta: U.S. Department of Health and Human Services, CDC, 2012. Available at: www.cdc.gov/narms/reports.htm, accessed May 25, 2012.
7. Daniels JB, Call DR, Hancock D, Sischo WM, Baker K, Besser TE. Role of ceftiofur in selection and dissemination of blaCMY-2- mediated cephalosporin resistance in Salmonella enterica and commensal Escherichia coli isolates from cattle. Appl Environ Microbiol 2009;75:3648-3655.
8. Donaldson SC, Straley BA, Hegde NV, Sawant AA, DebRoy C, Jayarao BM. Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves. Appl Environ Microbiol 2006;72:3940-3948. (Pubitemid 43894855)
9. Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, Wicklund J, Miller C, Holland B, Stamey K, Barrett TJ, Rasheed JK, Tenover FC, Ribot EM, Angulo FJ. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA 2000;284: 3151-3156. (Pubitemid 32039078)
10. [FAO] Food and Agriculture Organization of the United Nations. Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials. Report of the FAO/WHO/OIE Expert Meeting, FAO Headquarters, Rome, Italy, 26-30 November 2007. Rome: FAO, 2008. Available at: ftp://ftp.fao.org/docrep/fao/ 010/i0204e/i0204e00.pdf, accessed August 20, 2012.
11. Gelman A, Hill J. Data Analysis Using Regression and Multilevel/ Hierarchical Models. Cambridge, UK: Cambridge University Press, 2007.
12. Gupta A, Fontana J, Crowe C, Bolstorff B, Stout A, Van DS, Hoekstra MP, Whichard JM, Barrett TJ, Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003;188: 1707-1716. (Pubitemid 38010682)
13. Hancock DD, Besser TE, Rice DH. Ecology of Escherichia coli O157:H7 in cattle and impact of management practices. In: Escherichia coli O157:H7 and Other Shigatoxin-Producing E. coli Strains. Kaper JB, O'Brian AD (eds.). Washington, DC: American Society for Microbiology, 1998, p. 85.
14. Heider LC, Funk JA, Hoet AE, Meiring RW, Gebreyes WA, Wittum TE. Identification of Escherichia coli and Salmonella enterica organisms with reduced susceptibility to ceftriaxone from fecal samples of cows in dairy herds. Am J Vet Res 2009; 70:389-393.
15. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001;32:263-269. (Pubitemid 32524797)
16. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009;22: 161-182.
17. Jiang X, Yang H, Dettman B, Doyle MP. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathog Dis 2006;3:355-365. (Pubitemid 46106311)
18. Lipsitch M, Samore M. Antimicrobial use and antimicrobial resistance: A population perspective. Emerg Infect Dis 2002;8: 347-354. (Pubitemid 34415194)
19. Lowrance TC, Loneragan GH, Kunze DJ, Platt TM, Ives SE, Scott HM, Norby B, Echeverry A, Brashears MM. Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. Am J Vet Res 2007;68:501-507. (Pubitemid 46824932)
20. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput 2000;10:325-337.
21. Mann S, Siler JD, Jordan D, Warnick LD. Antimicrobial susceptibility of fecal Escherichia coli isolates in dairy cows following systemic treatment with ceftiofur or penicillin. Foodborne Pathog Dis 2011;8:861-867.
22. Marshall BM, Levy SB. Food animals and antimicrobials: Impacts on human health. Clin Microbiol Rev 2011;24: 718-733.
23. Martin-Laurent F, Philippot L, Hallet S, Chaussod R, Germon JC, Soulas G, Catroux G. DNA extraction from soils: Old bias for new microbial diversity analysis methods. Appl Environ Microbiol 2001;67:2354-2359. (Pubitemid 33641427)
24. McCoach DB, Kaniskan B. Using time-varying covariates in multilevel growth models. Front Psychol 2010;1:17.
25. Mumy KL, Findlay RH. Convenient determination of DNA extraction efficiency using an external DNA recovery standard and quantitative-competitive PCR. J Microbiol Methods 2004; 57:259-268. (Pubitemid 38446871)
26. Patterson SK, Singer RS. Development of a polymerase chain reaction assay for the detection of antibiotic resistance genes in community DNA. J Vet Diagn Invest 2006;18:172-181.
27. Pfizer Animal Health. Excenel RTU. Available at: https:// animalhealth.pfizer.com/sites/pahweb/US/EN/Products/ Pages/Excenel.aspx, accessed May 25, 2012.
28. Poole K. Resistance to beta-lactam antibiotics. Cell Mol Life Sci 2004;61:2200-2223.
29. Rankin SC, Aceto H, Cassidy J, Holt J, Young S, Love B, Tewari D, Munro DS, Benson CE. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol 2002; 40:4679-4684. (Pubitemid 35434967)
30. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology. Krawetz S, Misener S (eds.). Totowa, NJ: Humana Press, 2000, pp. 365-386.
31. Singer RS, Patterson SK, Wallace RL. Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract. Appl Environ Microbiol 2008;74: 6956-6962.
32. Tragesser LA, Wittum TE, Funk JA, Winokur PL, Rajala-Schultz PJ. Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am J Vet Res 2006;67:1696-1700. (Pubitemid 44605286)
33. [FDA] U.S. Food and Drug Administration. FDA to protect important class of antimicrobial drugs for treating human illness. 2012. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm285704.htm, accessed May 25, 2012.
34. Whichard JM, Joyce K, Fey PD, Nelson JM, Angulo FJ, Barrett TJ. Beta-lactam resistance and Enterobacteriaceae, United States. Emerg Infect Dis 2005;11:1464-1466. (Pubitemid 41209149)
35. Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, Doern GV. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC betalactamase. Antimicrob Agents Chemother 2000;44:2777-2783.
36. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001;45:2716-2722. (Pubitemid 32906662)
37. Zaidi MB, Leon V, Canche C, Perez C, Zhao S, Hubert SK, Abbott J, Blickenstaff K, McDermott PF. Rapid and widespread dissemination of multidrug-resistant blaCMY-2 Salmonella Typhimurium in Mexico. J Antimicrob Chemother 2007;60: 398-401. (Pubitemid 47243892)